News | Cardiovascular Business | April 25, 2018

FDA Announces New Medical Device Safety Action Plan

Document outlines the agency’s plan to encourage device innovation while protecting patient safety and informing patients and providers

FDA Announces New Medical Device Safety Action Plan

April 25, 2018 — The U.S. Food and Drug Administration (FDA) released a new Medical Device Safety Action Plan outlining how the agency will encourage medical device innovation to improve safety, detect safety risks earlier, and keep doctors and patients better informed.  

“All medical devices have benefits and risks. And some of these risks are better understood once the device is more widely distributed and used under real-world conditions, in broader patient populations, and by a broader range of clinicians,” said FDA Commissioner Scott Gottlieb, M.D. “Our aim is to ensure not only that devices meet the gold standard for getting to market, but also that they continue to meet this standard as we get more data about devices and learn more about their benefit-risk profile in real world clinical settings.”

In the plan, subtitled “Protecting Patients, Promoting Public Health,” the FDA describes key actions it will take in the following areas:

  • Establish a robust medical device patient safety net in the United States;
  • Explore regulatory options to streamline and modernize timely implementation of postmarket mitigations;
  • Spur innovation towards safer medical devices;
  • Advance medical device cybersecurity; and
  • Integrate the Center for Devices and Radiological Health’s (CDRH’s) premarket and postmarket offices and activities to advance the use of a Total Product Life Cycle (TPLC) approach to device safety.

The FDA welcomes comments and feedback on this proposal and encourages other ideas and suggestions on how it can strengthen its regulatory programs. Input may be submitted through the public docket (FDA-2018-N-1315) at www.regulations.gov.

For more information: www.fda.gov

 


Related Content

News | Cardiovascular Business

December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for ...

Home December 07, 2022
Home
Feature | Cardiovascular Business

Here is a recap of what DAIC viewers found most interesting during the month of November: 1. Study Finds That Risk of ...

Home December 05, 2022
Home
Feature | Cardiovascular Business | By Merilee Kern, MBA

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

Home November 09, 2022
Home
News | Cardiovascular Business

November 1, 2022 — Deepak L. Bhatt, MD, MPH, a top expert in cardiovascular medicine and interventional cardiology, has ...

Home November 01, 2022
Home
Feature | Cardiovascular Business

November 1, 2022 — Johnson & Johnson and Abiomed, a world leader in breakthrough heart, lung and kidney support ...

Home November 01, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

Home November 01, 2022
Home
News | Cardiovascular Business

October 31, 2022 — The Yale School of Medicine announced the passing of Robert W. Berliner Professor Emeritus of ...

Home October 31, 2022
Home
News | Cardiovascular Business

October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine ...

Home October 24, 2022
Home
News | Cardiovascular Business

October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

Home October 20, 2022
Home
News | Cardiovascular Business

October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named ...

Home October 19, 2022
Home
Subscribe Now